FDA News: Forceful steps for Opioid Crisis, Cybersecurity Workshop
FDA BRIEF: Week of May 22, 2017
FDA Commissioner Asks Staff for ‘More Forceful Steps’ to Stem the Opioid Crisis
By: Scott Gottlieb, M.D., Commissioner. @SGottliebFDA
Highest initial priority is reduce epidemic of opioid addiction; Establishing Opioid Steering Committee
- Explore and develop additional FDA tools to answer following questions
- ? Mandatory education for health care professionals: appropriate prescribing recommendations, identify abuse risk, treat addicted patients
- ? Additional risk management to tailor prescription of opioid doses
- ? Proper policy framework for risk of abuse and misuse
Public Workshop – Cybersecurity of Medical Devices: A Regulatory Science Gap Analysis
Hosted by FDA, National Science Foundation (NSF) and Department of Homeland Security, Science and Technology (DHS, S&T)
Purpose
- Examine opportunities for FDA engagement with new and ongoing research
- Catalyze collaboration among stakeholders to identify regulatory science challenges
- Discuss innovative strategies to address those challenges
- Encourage proactive development of analytical tools, processes, and best practices